A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology

Journal of Immune Based Therapies and Vaccines

Volumn 6, Issue , 2008, Pages

  Campbell Anson, Ryan E ^a   Kentor, Diane ^a   Wang, Yi J ^a   Bushnell, Kathryn M ^a   Li, Yufeng ^a   Vence, Luis M ^a   Radvanyi, Laszlo G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; COST CONTROL; CULTURE TECHNIQUE; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LARGE SCALE PRODUCTION; LEUKAPHERESIS; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; ROLLER BOTTLE CULTURE TECHNOLOGY; T LYMPHOCYTE ACTIVATION; TIME MANAGEMENT; VACCINE PRODUCTION;

EID: 42349086204     PISSN: None     EISSN: 14768518     Source Type: Journal    
DOI: 10.1186/1476-8518-6-1     Document Type: Article

References (19)

1. Steinman RM Hemmi H Dendritic cells: Translating innate to adaptive immunity Curr Top Microbiol Immunol 2006, 311:17-58. 17048704
2. Banchereau J Palucka AK Dendritic cells as therapeutic vaccines against cancer Nat Rev Immunol 2005, 5(4):296-306. 15803149 10.1038/nri1592
3. Andrieu JM Lu W A dendritic cell-based vaccine for treating HIV infection: Background and preliminary results J Intern Med 2007, 261(2):123-131. 17241177 10.1111/j.1365-2796.2006.01738.x
4. Nestle FO Farkas A Conrad C Dendritic-cell-based therapeutic vaccination against cancer Curr Opin Immunol 2005, 17(2):163-169. 15766676 10.1016/ j.coi.2005.02.003
5. Osada T Clay TM Woo CY Morse MA Lyerly HK Dendritic cell-based immunotherapy Int Rev Immunol 2006, 25(5-6):377-413. 17169781 10.1080/ 08830180600992456
6. Vieweg J Jackson A Modulation of antitumor responses by dendritic cells Springer Semin Immunopathol 2005, 26(3):329-341. 15609005 10.1007/ s00281-004-0175-1
7. Pilon-Thomas SA Verhaegen ME Mule JJ Dendritic cell-based therapeutics for breast cancer Breast Dis 2004, 20:65-71. 15687708
8. Paczesny S Banchereau J Wittkowski KM Saracino G Fay J Palucka AK Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells J Exp Med 2004, 199(11):1503-1511. 15173207 10.1084/jem.20032118 2211788
9. Di Nicola M Carlo-Stella C Mortarini R Baldassari P Guidetti A Gallino GF Del Vecchio M Ravagnani F Magni M Chaplin P Cascinelli N Parmiani G Gianni AM Anichini A Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: A phase I trial in metastatic melanoma Clin Cancer Res 2004, 10(16):5381-5390. 15328176 10.1158/1078-0432.CCR-04-0602
10. Palucka AK Ueno H Connolly J Kerneis-Norvell F Blanck JP Johnston DA Fay J Banchereau J Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity J Immunother 2006, 29(5):545-557. 16971810 10.1097/ 01.cji.0000211309.90621.8b
11. Tuyaerts S Noppe SM Corthals J Breckpot K Heirman C De Greef C Van Riet I Thielemans K Generation of large numbers of dendritic cells in a closed system using Cell Factories J Immunol Methods 2002, 264(1-2):135-151. 12191517 10.1016/S0022-1759(02)00099-6
12. Felzmann T Witt V Wimmer D Ressmann G Wagner D Paul P Huttner K Fritsch G Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection Cytotherapy 2003, 5(5):391-398. 14578101 10.1080/14653240310003053
13. Berger TG Feuerstein B Strasser E Hirsch U Schreiner D Schuler G Schuler-Thurner B Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories J Immunol Methods 2002, 268(2):131-140. 12215381 10.1016/S0022-1759(02)00189-8
14. Buchler T Kovarova L Musilova R Bourkova L Ocadlikova D Bulikova A Hanak L Michalek J Hajek R Generation of dendritic cells using cell culture bags--description of a method and review of literature Hematology 2004, 9(3):199-205. 15204101 10.1080/10245330410001701486
15. Kurlander RJ Tawab A Fan Y Carter CS Read EJ A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks Transfusion 2006, 46(9):1494-1504. 16965575 10.1111/j.1537-2995.2006.00940.x
16. Spisek R Bretaudeau L Barbieux I Meflah K Gregoire M Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use Cancer Immunol Immunother 2001, 50(8):417-427. 11726136 10.1007/s002620100215
17. Mailliard RB Wankowicz-Kalinska A Cai Q Wesa A Hilkens CM Kapsenberg ML Kirkwood JM Storkus WJ Kalinski P alpha-type-1 polarized dendritic cells: A novel immunization tool with optimized CTL-inducing activity Cancer Res 2004, 64(17):5934-5937. 15342370 10.1158/0008-5472.CAN-04-1261
18. Currier JR Kuta EG Turk E Earhart LB Loomis-Price L Janetzki S Ferrari G Birx DL Cox JH A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays J Immunol Methods 2002, 260(1-2):157-172. 11792386 10.1016/S0022-1759(01)00535-X
19. He L Hakimi J Salha D Miron I Dunn P Radvanyi L A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells J Immunol Methods 2005, 304(1-2):43-59. 16076473